HighTower Advisors’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

HighTower Advisors’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-108,794	Closed	-$1.07M	–	3611
2022 Q3	$1.07M	Sell	108,794 -8,330	-7%	-$82.1K	﹤0.01%	1569
2022 Q2	$1.14M	Sell	117,124 -6,092	-5%	-$59.8K	﹤0.01%	1564
2022 Q1	$1.2M	Sell	123,216 -4,500	-4%	-$43.9K	﹤0.01%	1649
2021 Q4	$1.25M	Sell	127,716 -970	-0.8%	-$9.47K	﹤0.01%	1643
2021 Q3	$1.25M	Sell	128,686 -174	-0.1%	-$1.68K	﹤0.01%	1527
2021 Q2	$1.24M	Sell	128,860 -3,490	-3%	-$33.9K	﹤0.01%	1506
2021 Q1	$1.27M	Buy	+132,350	New	+$1.28M	﹤0.01%	1441

HighTower Advisors's SHAC Position: Q4 2022 in Review

HighTower Advisors sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 108,794 shares — an estimated $1.07M sold.

HighTower Advisors first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.27M in Q1 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

HighTower Advisors reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
HighTower Advisors sold 108,794 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $1.07M.
HighTower Advisors first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
HighTower Advisors's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.27M in Q1 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.